Avtor/Urednik		Therasse, P; Mauriac, L; Welnicka, M; Bruning, P; Čufer, T; Lichinitser, R; Pluzanska, A; Tomiak, E; Koopmanschap, M; Piccart, M
Naslov		The added value of the combined evaluation of clinical efficacy, quality of life and cost-effectiveness in a randomized phase III study: results of an EORTC-NCIC-SAKK neoadjuvant trial in patients with locally advanced breast cancer (LABC)
Tip		članek
Vir		Eur J Cancer
Vol. in št.		Letnik 35, št. Suppl 4
Leto izdaje		1999
Obseg		str. S313
Jezik		eng
Deskriptorji		BREAST NEOPLASMS CLINICAL TRIALS, PHASE III QUALITY OF LIFE COST-BENEFIT ANALYSIS